Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz714
Abstract: Abstract Aims To evaluate the long-term use of secondary prevention medications [statins, β-blockers, renin–angiotensin–aldosterone system (RAAS) inhibitors, and platelet inhibitors] after coronary artery bypass grafting (CABG) and the association between medication use and mortality. Methods… read more here.
Keywords: long term; raas inhibitors; secondary prevention; prevention medications ... See more keywords
Predictors of vein graft disease progression between one week and one year after surgical coronary revascularization: Impact of secondary prevention medications
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.16895
Abstract: This study aimed to detect the predictors of vein graft disease (VGD) progression between 1 week and 1 year after surgery and to evaluate the impact of secondary prevention medications. read more here.
Keywords: secondary prevention; predictors vein; vein graft; graft disease ... See more keywords
A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
Sign Up to like & getrecommendations! Published in 2020 at "Patient preference and adherence"
DOI: 10.2147/ppa.s257323
Abstract: Purpose Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers… read more here.
Keywords: secondary prevention; qualitative study; ischemic attack; stroke transient ... See more keywords